Stephen N. Oesterle insider trades

Open-market stock purchases and sales by Stephen N. Oesterle, Director at Baxter International Inc, from SEC Form 4 filings since Feb 6, 2017.

Recent trades

No open-market trades in the last 12 months.

Companies traded

BAX Baxter International Inc: other filings, last May 6, 2025
FNA Paragon 28, Inc: other filings, last Apr 21, 2025
SGTX Sigilon Therapeutics, Inc: other filings, last Aug 11, 2023
RVA.AX REVA Medical, Inc: 1 buy, last Jun 29, 2018

Get free alerts when Stephen N. Oesterle files a new trade →